These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19738989)

  • 1. Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients.
    Farouk HM; Mansour HE; Rahman SA; Mostafa AA; Shamy HA; Zarouk WA
    Braz J Med Biol Res; 2009 Sep; 42(9):831-8. PubMed ID: 19738989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Charpin C; Balandraud N; Guis S; Roudier C; Toussirot E; Rak J; Lambert N; Martin M; Reviron D; Roudier J; Auger I
    Clin Exp Rheumatol; 2008; 26(4):627-31. PubMed ID: 18799094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.
    Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kobashigawa T; Tokunaga K; Tsuchiya N; Kamatani N; Kotake S
    Clin Exp Rheumatol; 2007; 25(2):219-24. PubMed ID: 17543145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis.
    Furuya T; Matsumoto I; Tsuchiya N; Hakoda M; Ichikawa N; Yago T; Higami K; Nanke Y; Sumida T; Kamatani N; Kotake S
    Clin Exp Rheumatol; 2008; 26(5):918-21. PubMed ID: 19032829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
    Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
    Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies.
    Louzada-Júnior P; Freitas MV; Oliveira RD; Deghaide NH; Conde RA; Bertolo MB; Donadi EA
    Braz J Med Biol Res; 2008 Jun; 41(6):493-9. PubMed ID: 18560674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
    Bang SY; Lee HS; Lee KW; Bae SC
    J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
    Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
    Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.
    Hughes LB; Morrison D; Kelley JM; Padilla MA; Vaughan LK; Westfall AO; Dwivedi H; Mikuls TR; Holers VM; Parrish LA; Alarcón GS; Conn DL; Jonas BL; Callahan LF; Smith EA; Gilkeson GS; Howard G; Moreland LW; Patterson N; Reich D; Bridges SL
    Arthritis Rheum; 2008 Feb; 58(2):349-58. PubMed ID: 18240241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis.
    Iwamoto N; Kawakami A; Arima K; Tamai M; Nakamura H; Kawashiri SY; Kita J; Okada A; Koga T; Kamachi M; Yamasaki S; Ichinose K; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2011 Jun; 21(3):240-3. PubMed ID: 21107991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
    Senkpiehl I; Marget M; Wedler M; Jenisch S; Georgi J; Kabelitz D; Steinmann J
    Int Arch Allergy Immunol; 2005 Aug; 137(4):315-8. PubMed ID: 15970640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.